Marcos C. Miranda

2.6k total citations · 1 hit paper
10 papers, 451 citations indexed

About

Marcos C. Miranda is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Marcos C. Miranda has authored 10 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Infectious Diseases. Recurrent topics in Marcos C. Miranda's work include SARS-CoV-2 and COVID-19 Research (3 papers), Immunotherapy and Immune Responses (3 papers) and RNA and protein synthesis mechanisms (3 papers). Marcos C. Miranda is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (3 papers), Immunotherapy and Immune Responses (3 papers) and RNA and protein synthesis mechanisms (3 papers). Marcos C. Miranda collaborates with scholars based in United States, United Kingdom and Sweden. Marcos C. Miranda's co-authors include David Baker, David Veesler, Hansol Lee, Byung‐Ha Oh, Hyo Jeong Hong, Alfredo Quijano‐Rubio, Lance Stewart, Cameron M. Chow, Hsien‐Wei Yeh and Scott E. Boyken and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Marcos C. Miranda

10 papers receiving 447 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

De novo design of modular and tunable protein biosensors

2021 170 citations Alfredo Quijano‐Rubio, Hsien‐Wei Yeh et al. Nature profile →

Peers

Countries citing papers authored by Marcos C. Miranda

Since Specialization

Citations

This map shows the geographic impact of Marcos C. Miranda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcos C. Miranda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcos C. Miranda more than expected).

Fields of papers citing papers by Marcos C. Miranda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcos C. Miranda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcos C. Miranda. The network helps show where Marcos C. Miranda may publish in the future.

Co-authorship network of co-authors of Marcos C. Miranda

This figure shows the co-authorship network connecting the top 25 collaborators of Marcos C. Miranda. A scholar is included among the top collaborators of Marcos C. Miranda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcos C. Miranda. Marcos C. Miranda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Immunogenicity and innate immunity to high-dose and repeated vaccination of modified mRNA versus unmodified mRNA 2025 ·Molecular Therapy — Nucleic Acids ·(unknown), (unknown), Marcos C. Miranda, Xianglei Yan, Klara Lenart, (unknown), Annika Reinhardt, Karin Loré	1
2	Biochemical and hematological reference intervals in rhesus and cynomolgus macaques and implications for vaccine and drug development 2025 ·Lab Animal ·Xianglei Yan, (unknown), Sebastian Ols, Klara Lenart, Fredrika Hellgren, Marcos C. Miranda, (unknown), Annika Reinhardt, Bengt I. Eriksson, Karin Loré	2
3	Local structural flexibility drives oligomorphism in computationally designed protein assemblies 2025 ·Nature Structural & Molecular Biology ·Alena Khmelinskaia, Neville P. Bethel, (unknown), (unknown), Aleksandar Antanasijevic, Andrew J. Borst, Szu‐Hsueh Lai, (unknown), Jing Yang Wang, Marcos C. Miranda, Andrew M. Watkins, Cassandra Ogohara, (unknown), Mengyu Wu, Albert J. R. Heck, David Veesler, Andrew B. Ward, David Baker, Reidun Twarock, Neil P. King	4
4	Design of Diverse Asymmetric Pockets in De Novo Homo-oligomeric Proteins 2023 ·Biochemistry ·Stacey Gerben, Andrew J. Borst, Derrick R. Hicks, (unknown), David Feldman, Brian Coventry, Wei Yang, Asim K. Bera, Marcos C. Miranda, Alex Kang, Hannah Nguyen, David Baker	2
5	Precisely patterned nanofibres made from extendable protein multiplexes 2023 ·Nature Chemistry ·Neville P. Bethel, Andrew J. Borst, Fabio Parmeggiani, Matthew J. Bick, TJ Brunette, Hannah Nguyen, Alex Kang, Asim K. Bera, Lauren Carter, Marcos C. Miranda, Ryan D. Kibler, Mila Lamb, Xinting Li, Banumathi Sankaran, David Baker	17
6	IgM antibodies derived from memory B cells are potent cross-variant neutralizers of SARS-CoV-2 2022 ·The Journal of Experimental Medicine ·Malika Hale, Jason Netland, (unknown), Christopher D. Thouvenel, (unknown), Lucille M. Rich, (unknown), Marcos C. Miranda, Julie Eggenberger, Linhui Hao, Michael J. Watson, (unknown), Lauren B. Rodda, Neil P. King, Miklós Guttman, Michael Gale, Jonathan Abraham, Jason S. Debley, Marion Pepper, David J. Rawlings	24
7	Structure, receptor recognition, and antigenicity of the human coronavirus CCoV-HuPn-2018 spike glycoprotein 2022 ·Cell ·M. Alejandra Tortorici, Alexandra C. Walls, Anshu Joshi, Young‐Jun Park, Rachel Eguia, Marcos C. Miranda, Elizabeth Kepl, Annie Dosey, Terry Stevens‐Ayers, Michael Boeckh, Amalio Telenti, Antonio Lanzavecchia, Neil P. King, Davide Corti, Jesse D. Bloom, David Veesler	39
8	Multimeric antibodies from antigen-specific human IgM+ memory B cells restrict Plasmodium parasites 2021 ·The Journal of Experimental Medicine ·Christopher D. Thouvenel, Mary F. Fontana, Jason Netland, Akshay T. Krishnamurty, Kennidy K. Takehara, (unknown), Suruchi Singh, Kazutoyo Miura, Gladys J. Keitany, Eric M. Lynch, Sílvia Portugal, Marcos C. Miranda, Neil P. King, Justin M. Kollman, Peter D. Crompton, Carole A. Long, Marie Pancera, David J. Rawlings, Marion Pepper	20
9	Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants 2021 ·Science ·Matthew McCallum, Alexandra C. Walls, Kaitlin R. Sprouse, John E. Bowen, Laura E. Rosen, Ha V. Dang, Anna De Marco, Nicholas Franko, Sasha W. Tilles, Jennifer K. Logue, Marcos C. Miranda, Maggie Ahlrichs, Lauren Carter, Gyorgy Snell, Matteo Samuele Pizzuto, Helen Y. Chu, Wesley C. Van Voorhis, Davide Corti, David Veesler	172
10	De novo design of modular and tunable protein biosensors breakdown → 2021 ·Nature ·Alfredo Quijano‐Rubio, Hsien‐Wei Yeh, (unknown), Hansol Lee, Robert A. Langan, Scott E. Boyken, Marc J. Lajoie, Longxing Cao, Cameron M. Chow, Marcos C. Miranda, (unknown), Hyo Jeong Hong, Lance Stewart, Byung‐Ha Oh, David Baker	170

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact